Leading researchers showcase cutting-edge bioengineering and bioprinting technologies — from organ-on-a-chip models to 3D-printed vasculature — driving new insights into pulmonary hypertension mechanisms and therapies.
Join us 28 January – 1 February as we celebrate 20 years of progress and innovation in PH. This year’s programme highlights advances in PAH, CTEPH, and PH in lung disease, with sessions on emerging therapies, precision medicine, and future directions.
Join us for two optional fundraising activities at PVRI 2026 Dublin as we celebrate 20 years of global collaboration. Take part in our morning run/walk or relaxed pub social and help support PVRI’s mission to advance PH awareness, research, and care worldwide.
Living Legend Stuart Rich shares insights from four decades of pioneering research that transformed the understanding and treatment of pulmonary hypertension, in conversation with Serpil Erzurum and Saad Kubba.
Leading experts explore how exercise physiology, metabolism, and the microbiome are reshaping our understanding of body composition and its role in pulmonary hypertension.
Living Legend Paul Corris reflects on a career that shaped global lung transplantation and pulmonary hypertension care, sharing his insights and experiences with Patricia Thistlethwaite and Nolan Winicki.
Experts and advocates explore the genetics, biology, and clinical management of TBX4 syndrome, bridging discoveries from bench to bedside to advance understanding and care.
Living Legend Marlene Rabinovitch shares the discoveries that transformed our understanding of pulmonary vascular disease and reflects on a career dedicated to advancing science and mentoring the next generation.
